These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Plasma exchange in the management of severe rhesus haemolytic disease. Halligan A; McGuinness EP Ir Med J; 1990 Sep; 83(3):107-8. PubMed ID: 2121660 [TBL] [Abstract][Full Text] [Related]
47. Early intraperitoneal transfusion and adjuvant maternal immunoglobulin therapy in the treatment of severe red cell alloimmunization prior to fetal intravascular transfusion. Fox C; Martin W; Somerset DA; Thompson PJ; Kilby MD Fetal Diagn Ther; 2008; 23(2):159-63. PubMed ID: 18046076 [TBL] [Abstract][Full Text] [Related]
48. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment. van Kamp IL; Klumper FJ; Bakkum RS; Oepkes D; Meerman RH; Scherjon SA; Kanhai HH Am J Obstet Gynecol; 2001 Sep; 185(3):668-73. PubMed ID: 11568796 [TBL] [Abstract][Full Text] [Related]
49. [Intrauterine intravascular fetal transfusion under ultrasonic guide in Rh isoimmunization: a case report]. Tanigawara S; Okamura K; Watanabe T; Endo H; Shintaku Y; Akiyama N; Iwamoto M; Shinkawa O; Yajima A; Sakai T Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):621-4. PubMed ID: 2502588 [No Abstract] [Full Text] [Related]
50. [Treatment of fetal hemolytic disease by hemosorption]. Sergienko NS; Malinovskaia SIa; Sichinava LG Akush Ginekol (Mosk); 1989 Sep; (9):56-9. PubMed ID: 2512819 [TBL] [Abstract][Full Text] [Related]
51. [Intrauterine blood transfusion in severe erythrocyte stimulation. A necessary intervention but not without risks]. Engkvist F; Wåhlin M; Axelsson O Lakartidningen; 2008 Nov 12-18; 105(46):3329-33. PubMed ID: 19062624 [No Abstract] [Full Text] [Related]
52. Consequences of fetomaternal haemorrhage after intrauterine transfusion. Nicolini U; Kochenour NK; Greco P; Letsky EA; Johnson RD; Contreras M; Rodeck CH BMJ; 1988 Nov; 297(6660):1379-81. PubMed ID: 2464380 [TBL] [Abstract][Full Text] [Related]
54. [The first intrauterine transfusion in Poland. Current problems and new achievements in this field]. Lozińska D Acta Haematol Pol; 1988; 19(3-4):193-8. PubMed ID: 3075395 [No Abstract] [Full Text] [Related]
55. [Diagnosis and therapy in fetuses at risk in Rh isoimmunization]. Calda P; Zizka Z; Rezábek K; Masata J; Bendl J Cesk Gynekol; 1993 Dec; 58(6):278-82. PubMed ID: 8293503 [TBL] [Abstract][Full Text] [Related]
56. ACOG Practice Bulletin No. 192: Management of Alloimmunization During Pregnancy. Obstet Gynecol; 2018 Mar; 131(3):e82-e90. PubMed ID: 29470342 [TBL] [Abstract][Full Text] [Related]
57. [Intravascular transfusion in Rh isoimmunization and its associated problems]. Mitsuda N; Iwata M; Yanahashi A; Ohashi K; Takagi T; Tanizawa O; Nagamine K; Kurata Y; Nakajima S; Seino Y Nihon Sanka Fujinka Gakkai Zasshi; 1990 Sep; 42(9):1267-70. PubMed ID: 2120374 [No Abstract] [Full Text] [Related]
59. ACOG Practice Bulletin No. 192 Summary: Management of Alloimmunization During Pregnancy. Obstet Gynecol; 2018 Mar; 131(3):611-612. PubMed ID: 29470338 [TBL] [Abstract][Full Text] [Related]
60. The role of hysterotomy and prenatal exchange transfusion in the management of severe erythroblastosis fetalis. Adamsons K Bibl Gynaecol; 1966; 38():160-8. PubMed ID: 5950087 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]